About: http://webisa.webdatacommons.org/222940167

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	and Mylan have refused to cooperate with big pharmaceutical companies, while others, such as Par and Watson Pharmaceuticals, reportedly do collaborate.Still, none of the genric-makers wants to scrap the the exclusivity period.
http://www.w3.org/ns/prov#wasQuotedFrom	blogspot.com